The Amplify Weight Loss Drug & Treatment ETF (THNR) seeks investments results that generally correspond to the performance of the VettaFi Weight Loss Drug & Treatment Index. THNR provides access to global companies involved in the pharmaceutical manufacturing of GLP-1 agonist or enablers of such businesses.
Amplify ETFs Declares January Income Distributions for its Income ETFs
Amplify ETFs Declares January Income Distributions for its Income ETFs
Amplify ETFs Enhances NDIV with Covered Calls, Targeting High Income and Capital Appreciation
Amplify ETFs Enhances NDIV with Covered Calls, Targeting High Income and Capital Appreciation
The Cannabis Recap - February 4, 2026
Growth, Fed Policy, and Metals: Three Forces Shaping Markets
Amplify Weight Loss Drug & Treatment ETF (THNR) 4th Quarter Commentary 2025
The Cannabis Recap - February 10, 2026
Amplify ETFs Files for Amplify Municipal CEF High Income ETF (YYYM)
Amplify ETFs Files for Amplify Municipal CEF High Income ETF (YYYM)